Mydecine Innovations Group (Mydecine Innovations Group) Total Equity : $-4.82 Mil (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Mydecine Innovations Group Total Equity?

Mydecine Innovations Group's total equity for the quarter that ended in Sep. 2023 was $-4.82 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Mydecine Innovations Group Total Equity Historical Data

The historical data trend for Mydecine Innovations Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Total Equity Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Equity

Get a 7-Day Free Trial

0.05

1.39

2.78

0.17

-2.65

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Equity	Get a 7-Day Free Trial															-3.05	-2.65	-5.89	-6.84	-4.82

Mydecine Innovations Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Mydecine Innovations Group's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2022 )	-	Total Liabilities(Q: Dec. 2022 )
	=	5.08	-	7.73
	=	-2.65

Mydecine Innovations Group's Total Equity for the quarter that ended in Sep. 2023 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2023 )	-	Total Liabilities(Q: Sep. 2023 )
	=	3.292	-	8.109
	=	-4.82

Mydecine Innovations Group Total Equity Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group (Mydecine Innovations Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (OTCPK:MYCOF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

MYIG:UK 0NF0:Germany MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.